Charles River Laboratories International, Inc. (NYSE: CRL) announces that it has signed definitive agreements to sell certain European Discovery Services assets as well as the CDMO and Cell Solutions businesses in separate transactions. Charles River has signed a definitive agreement to divest its CDMO and Cell Solutions businesses to GI Partners, primarily for future, contingent performance-based payments. The Company will sell its CDMO sites in Tennessee, Maryland, and the United Kingdom and its Cell Solutions site in California. Separately, Charles River has signed a definitive agreement to divest certain European assets within its Discovery Services business to IQVIA Holdings Inc. for approximately $145 million in cash.
Read the full article: Charles River Laboratories Provides Update on Planned Divestitures //
Source: https://www.businesswire.com/news/home/20260224712091/en/Charles-River-Laboratories-Provides-Update-on-Planned-Divestitures